Abstract
d-Amphetamine, in doses lower than required to increase motor activity, reduced mouse spontaneous locomotor activity when this was assessed using cages equipped with photocell units, using treadwheels, or the measurement of spontaneous climbing behaviour. Actue treatments with the serotonergic agonists quipazine and 5-hydroxy-dl-tryptophan also reduced wheel running activity, spontaneous locomotor activity assessed using photocell cages, and spontaneous climbing behaviour; fenfluramine caused a similar effect. Pretreatment with 5-hydroxy-dl-tryptophan enhanced the inhibitory effects of d-amphetamine. A 3-day treatment with fenfluramine, or lesions of the median raphe nucleus (but not the dorsal raphe nucleus) abolished the ability of d-amphetamine to reduce motor activity in the three test systems. It is concluded that low doses of d-amphetamine can reduce locomotor activity and that the effects may be mediated via an enhancement of the release of 5-hydroxytryptamine from the system arising in the median raphe nucleus.
Similar content being viewed by others
References
Asin KE, Fibiger HC (1984) Spontaneous and delayed spatial alternation following damage to specific neuronal elements within the nucleus medians raphe. Behav Brain Res 13:241–250
Balfour DJK, Iyaniwura TT (1985) An investigation of amphetamine-induced release of 5-HT from rat hippocampal slices. Eur J Pharmacol 109:395–399
Boissier JR, Simon P, Fichelle J, Hervouet E (1965) Action psychoanaleptique de quelques anorexigènes dérivés de la phenyléthylamine. Thérapie 20:297–304
Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ, Smith JA (1985) Biochemical correlates of motor changes caused by the manipulation of dopamine function in the substantia nigra of the mouse. Neuropharmacology 24:1155–1161
Costa E, Groppetti A, Revuelta A (1971) Action of fenfluramine on monamine stores of rat tissues. Br J Pharmacol 41:57–64
Costall B, Naylor RJ (1975) The role of the raphe and extrapyramidal nuclei in the stereotyped and circling responses to quipazine. J Pharm Pharmacol 27:368–371
Costall B, Eniojukan JF, Naylor JR (1982) Spontaneous climbing behaviour of mice, its measurement and dopaminergic involvement. Eur J Pharmacol 85:125–132
Duhalt J, Verdavainne C (1967) Modification du taux de serotonine cerebrale chez la rat par les trifluoromethyl-phenyl-2-ethylaminopropane (fenfluramine, 768s). Arch Int Pharmacodyn Ther 170:276–286
Fuller RW, Snoddy HD, Perry KW, Roush BB, Molloy FR (1976) The effect of quipazine on serotonin metabolism in rat brain. Life Sci 18:925–934
Fuxe K (1965) Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol Scand [Suppl] 247:39–85
Green RA, Gillin JC, Wyatt RJ (1976) The inhibitory effect of intraventricular administration of serotonin on spontaneous motor activity of rats. Psychopharmacology 51:81–84
Harvey JA, McMaster SE, Fuller RW (1977) Comparison between the neurotoxic and serotonin-depletion effects of various halogenated derivatives of amphetamine in the rat. J Pharmacol Exp Ther 202:581–589
Hunsinger RN, Wilson MC (1985) Alteration of the neurochemical effects of fenfluramine by previous treatment with d-amphetamine. Pharmacol Biochem Behav 22:127–134
Hussey JS, Vincent ND, Davies JA (1983) The effect of low doses of d-amphetamine on drug-induced hyperactivity in the mouse. Psychopharmacology 81:327–331
Jacobs B, Wise WD, Taylor KM (1974) Differential behavioural and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats. Brain Res 79:35–361
Jacobs BL, Trimbach C, Eubanks EE, Trulson M (1975a) Hippocampal mediation of raphe lesion- and PCPA-induced hyperactivity in the rat. Brain Res 94:253–261
Jacobs BL, Wise WD, Taylor KM (1975b) Is their a catecholamine-serotonin interaction in the control of locomotor activity. Neuropharmacology 14:501–506
Kelley AE, Winnock M, Stinus L (1986) Amphetamine, apomorphine and investigatory behaviour in the rat: analysis of the structure and pattern of responses. Psychopharmacology 88:66–74
Kuczenski R (1979) Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover. Brain Res 164:217–225
Lorens SA, Köhler C, Guldberg HC (1975) Lesions in Gudden's tegmental nuclei produce behavioural and 5-HT effects similar to those after raphe lesions. Pharmacol Biochem Behav 3:653–659
Lorens SA, Guldberg HC, Hole K, Köhler C, Srebro B (1976) Activity, avoidance learning and regional 5-hydroxytryptamine following intra-brain stem 5,7-dihydroxytryptamine and electrolytic midbrain raphe lesions in the rat. Brain Res 108: 97–113
Lucki I, Harvey JA (1979) Increased sensitivity to d- and l-amphetamine action after midbrain raphe lesions as measured by locomotor activity. Neuropharmacology 18:243–249
Ponzio F, Consolazione A, Calderini G, Achilli G, Rochetti M, Algeri S (1981) Biochemical effects of quipazine on rat striatal dopaminergic system. Life Sci 29:83–91
Randrup A, Munkvad I (1966) Role of catecholamines in the amphetamine excitation response. Nature (Lond) 211:540–542
Robbins TW, Sahakian BJ (1983) Behavioural effects of psychomotor stimulant drugs: clinical and neuropsychological implications. In: Creese I (ed) Stimulants: Neurochemical, behavioural and chemical perspectives. Raven, New York, pp 301–338
Slotnick BM, Leonard CA (1975) A stereotaxic atlas of albino mouse forebrain. US Government Printing Office, Washington
Sloviter RS, Drust EG, Connor JD (1978) Evidence that serotonin mediates some behavioural effects of amphetamine. J Pharmacol Exp Ther 206:348–352
Steranka LR, Sanders-Bush E (1979) Long term effects of fenfluramine on central serotonergic mechanisms. Neuropharmacology 18:895–903
Trulson ME, Jacobs BL (1976) Behavioural evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur J Pharmacol 36:149–154
Warbritton JD, Stewart RM, Baldessarini RJ (1978) Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat. Brain Res 143:373–382
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bradbury, A.J., Costall, B., Naylor, R.J. et al. 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse. Psychopharmacology 93, 457–465 (1987). https://doi.org/10.1007/BF00207235
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00207235